Dual effects of the PI3K inhibitor ZSTK474 on multidrug efflux pumps in resistant cancer cells
- 1 November 2017
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 815, 127-137
Abstract
No abstract availableKeywords
Funding Information
- Worldwide Cancer Research
This publication has 37 references indexed in Scilit:
- Xanthines Down-Regulate the Drug Transporter ABCG2 and Reverse Multidrug ResistanceMolecular Pharmacology, 2012
- A fluorescence-based in vitro assay for drug interactions with breast cancer resistance protein (BCRP, ABCG2)European Journal of Pharmaceutics and Biopharmaceutics, 2009
- Transmembrane Helix 12 Modulates Progression of the ATP Catalytic Cycle in ABCB1Biochemistry, 2009
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancerCurrent Opinion in Pharmacology, 2006
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLSDrug Metabolism and Disposition, 2005
- Detailed characterization of cysteine‐less P‐glycoprotein reveals subtle pharmacological differences in function from wild‐type proteinBritish Journal of Pharmacology, 2001
- Synthesis and Function of 3-Phosphorylated Inositol LipidsAnnual Review of Biochemistry, 2001
- Both P-glycoprotein Nucleotide-binding Sites Are Catalytically ActiveJournal of Biological Chemistry, 1995